Evidence to decide the best treatment approach for Bell's Palsy still Lacking
Bell's palsy, a condition that affects the 7th cranial nerve, is the most common form of facial paralysis, accounting for 60 to 75% of cases. Isabella Menchetti and the team conducted a review study and addressed too little evidence to decide whether an operation would be helpful or harmful for people with early Bell's palsy. The review article was published in the journal Cochrane on January 26, 2021.
The research team searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, ClinicalTrials.gov and WHO ICTRP for the randomized controlled trials (RCTs) or quasi-RCTs involving any surgical intervention for Bell's palsy. They evaluated trials that compared surgical interventions to no treatment, later treatment (beyond three months), sham treatment, other surgical treatments or medical treatment to assess the effects of surgery in the early management of Bell's palsy. They found 2 studies that involved 65 people with Bell's palsy. The major outcome assessed was complete recovery of facial palsy at 12 months. They also assessed complete recovery at three and six months, synkinesis and contracture at 12 months, psychosocial outcomes at 12 months, and side effects and complications of treatment.
FIRST STUDY: The first study was a randomized control study of 24 participants that compared surgery with no treatment. There were no losses to follow-up. The findings reported have no differences between the surgical and no-treatment groups.
SECOND STUDY:
♦ The second study was a quasi-randomized study of 41 participants who were divided into early surgery, late surgery or non-surgical (no treatment) groups using alternation. This study lost three participants to follow-up, and 17 did not contribute to the assessment of secondary outcomes.
♦ The second study fully reported numerical data but included no statistical comparisons between groups for complete recovery. There was no evidence of a difference for the early surgery versus no treatment comparison (risk ratio (RR) 0.76; 33 participants; very low-certainty evidence) and for the early surgery versus late surgery comparison (RR 0.47; 26 participants; very low-certainty evidence).
♦ This study also reported a statistically significant decrease in lacrimal control in the surgical group within two to three months of denervation. Four had hearing loss and three had tinnitus.
Key findings of the study were:
• The research team wrote that the surgeons in both studies used a retro-auricular/transmastoid approach to decompress the facial nerve.
• They noted that neither study mentioned allocation concealment and neither participants nor outcome assessors were blinded to the interventions in either study which implies that both studies were at high risk of bias.
• They noted that the effects of surgery on facial nerve function at 12 months were very uncertain (2 RCTs, 65 participants; very low-certainty evidence).
• Because of the small numbers and trial design, the research team considered the evidence of the adverse effects as very uncertain (2 RCTs, 65 participants; very low-certainty evidence).
The authors concluded, "There is very low-certainty evidence from RCTs or quasi-RCTs on surgery for the early management of Bell's palsy, and this is insufficient to decide whether surgical intervention is beneficial or harmful".
They further mentioned, "Further research into the role of surgical intervention is unlikely to be performed because spontaneous or medically supported recovery occurs in most cases."
For further information:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.